keyword
https://read.qxmd.com/read/38643194/csf1r-antagonism-results-in-increased-supraspinal-infiltration-in-eae
#21
JOURNAL ARTICLE
Marilyn Wang, Sofia E Caryotakis, Glendalyn G Smith, Alan V Nguyen, David E Pleasure, Athena M Soulika
BACKGROUND: Colony stimulating factor 1 receptor (CSF1R) signaling is crucial for the maintenance and function of various myeloid subsets. CSF1R antagonism was previously shown to mitigate clinical severity in experimental autoimmune encephalomyelitis (EAE). The associated mechanisms are still not well delineated. METHODS: To assess the effect of CSF1R signaling, we employed the CSF1R antagonist PLX5622 formulated in chow (PLX5622 diet, PD) and its control chow (control diet, CD)...
April 20, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38642938/dysregulation-of-cd4-and-cd8-resident-memory-t-myeloid-and-stromal-cells-in-steroid-experienced-checkpoint-inhibitor-colitis
#22
JOURNAL ARTICLE
Jun Yan He, Yang-Joon Kim, Elvira Mennillo, Iulia Rusu, Jared Bain, Arjun A Rao, Christopher Andersen, Karen Law, Hai Yang, Jessica Tsui, Alan Shen, Brittany Davidson, Divyashree Kushnoor, Yimin Shi, Frances Fan, Alexander Cheung, Li Zhang, Lawrence Fong, Alexis J Combes, Angela O Pisco, Michael G Kattah, David Y Oh
BACKGROUND: Colitis caused by checkpoint inhibitors (CPI) is frequent and is treated with empiric steroids, but CPI colitis mechanisms in steroid-experienced or refractory disease are unclear. METHODS: Using colon biopsies and blood from predominantly steroid-experienced CPI colitis patients, we performed multiplexed single-cell transcriptomics and proteomics to nominate contributing populations. RESULTS: CPI colitis biopsies showed enrichment of CD4+ resident memory (RM) T cells in addition to CD8+ RM and cytotoxic CD8+ T cells...
April 19, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38642507/the-cd318-cd6-axis-limits-type-1-diabetes-islet-autoantigen-specific-human-t-cell-activation
#23
JOURNAL ARTICLE
Jeong-Su Do, David Arribas-Layton, Jemily Juan, Isaac Garcia, Sindhu Saraswathy, Meirigeng Qi, Enrique Montero, Helena Reijonen
CD6 is a glycoprotein expressed on CD4 and CD8 T cells involved in immunoregulation. CD318 has been identified as a CD6 ligand. The role of CD318 in T cell immunity is restricted as it has only been investigated in a few mice autoimmune models but not in human diseases. CD318 expression was thought to be limited to mesenchymal-epithelial cells and, therefore, contribute to CD6-mediated T cell activation in the CD318-expressing tissue rather than through interaction with antigen-presenting cells. Here, we report CD318 expression in a subpopulation of CD318+ myeloid dendritic (mDC), whereas the other peripheral blood populations were CD318 negative...
April 19, 2024: Journal of Autoimmunity
https://read.qxmd.com/read/38641750/an-autoantibody-signature-predictive-for-multiple-sclerosis
#24
JOURNAL ARTICLE
Colin R Zamecnik, Gavin M Sowa, Ahmed Abdelhak, Ravi Dandekar, Rebecca D Bair, Kristen J Wade, Christopher M Bartley, Kerry Kizer, Danillo G Augusto, Asritha Tubati, Refujia Gomez, Camille Fouassier, Chloe Gerungan, Colette M Caspar, Jessica Alexander, Anne E Wapniarski, Rita P Loudermilk, Erica L Eggers, Kelsey C Zorn, Kirtana Ananth, Nora Jabassini, Sabrina A Mann, Nicholas R Ragan, Adam Santaniello, Roland G Henry, Sergio E Baranzini, Scott S Zamvil, Joseph J Sabatino, Riley M Bove, Chu-Yueh Guo, Jeffrey M Gelfand, Richard Cuneo, H-Christian von Büdingen, Jorge R Oksenberg, Bruce A C Cree, Jill A Hollenbach, Ari J Green, Stephen L Hauser, Mitchell T Wallin, Joseph L DeRisi, Michael R Wilson
Although B cells are implicated in multiple sclerosis (MS) pathophysiology, a predictive or diagnostic autoantibody remains elusive. In this study, the Department of Defense Serum Repository (DoDSR), a cohort of over 10 million individuals, was used to generate whole-proteome autoantibody profiles of hundreds of patients with MS (PwMS) years before and subsequently after MS onset. This analysis defines a unique cluster in approximately 10% of PwMS who share an autoantibody signature against a common motif that has similarity with many human pathogens...
April 19, 2024: Nature Medicine
https://read.qxmd.com/read/38641698/lkb1-orchestrates-%C3%AE-%C3%AE-t-cell-metabolic-and-functional-fitness-to-control-il-17-mediated-autoimmune-hepatitis
#25
JOURNAL ARTICLE
Zhiqiang Xiao, Shanshan Wang, Liang Luo, Wenkai Lv, Peiran Feng, Yadong Sun, Quanli Yang, Jun He, Guangchao Cao, Zhinan Yin, Meixiang Yang
γδ T cells play a crucial role in immune surveillance and serve as a bridge between innate and adaptive immunity. However, the metabolic requirements and regulation of γδ T-cell development and function remain poorly understood. In this study, we investigated the role of liver kinase B1 (Lkb1), a serine/threonine kinase that links cellular metabolism with cell growth and proliferation, in γδ T-cell biology. Our findings demonstrate that Lkb1 is not only involved in regulating γδ T lineage commitment but also plays a critical role in γδ T-cell effector function...
April 19, 2024: Cellular & Molecular Immunology
https://read.qxmd.com/read/38641668/single-cell-transcriptomics-unveil-profiles-and-interplay-of-immune-subsets-in-rare-autoimmune-childhood-sj%C3%A3-gren-s-disease
#26
JOURNAL ARTICLE
Myung-Chul Kim, Umasankar De, Nicholas Borcherding, Lei Wang, Joon Paek, Indraneel Bhattacharyya, Qing Yu, Ryan Kolb, Theodore Drashansky, Akaluck Thatayatikom, Weizhou Zhang, Seunghee Cha
Childhood Sjögren's disease represents critically unmet medical needs due to a complete lack of immunological and molecular characterizations. This study presents key immune cell subsets and their interactions in the periphery in childhood Sjögren's disease. Here we show that single-cell RNA sequencing identifies the subsets of IFN gene-enriched monocytes, CD4+ T effector memory, and XCL1+ NK cells as potential key players in childhood Sjögren's disease, and especially in those with recurrent parotitis, which is the chief symptom prompting clinical visits from young children...
April 19, 2024: Communications Biology
https://read.qxmd.com/read/38641148/early-recovery-of-natural-killer-cells-post-t-cell-depleted-allogeneic-stem-cell-transplantation-using-alemtuzumab-in-the-bag
#27
JOURNAL ARTICLE
Glenda M Davison, Jessica J Opie, Saarah F G Davids, Rygana Mohammed, Nicolas Novitzky
BACKGROUND: Allogeneic stem cell transplantation (SCT) is a critical therapy for haematological malignancy but may lead to acute and chronic graft versus host disease (GvHD). T-cell depletion with alemtuzumab, either in vivo or ex vivo, reduces the incidence of GvHD but is a risk factor for disease relapse and poor immune reconstitution. Natural killer (NK) cells are the first lymphocytes to recover. Classical NK cells make up >90% of the normal circulating population and can directly kill neoplastic or virally infected cells while the regulatory subset makes up <10%, secretes cytokines and is not cytotoxic...
April 17, 2024: Transplant Immunology
https://read.qxmd.com/read/38640985/t-cell-involvement-in-antiphospholipid-syndrome
#28
REVIEW
Maria G Tektonidou, Nikolaos I Vlachogiannis, Petros P Sfikakis
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by arterial and venous thrombosis, and obstetric complications in the presence of antiphospholipid antibodies (aPL), including lupus anticoagulant, anticardiolipin and anti-β2-glycoprotein I antibodies, manifesting as single, or often as recurrent events, and rarely as a catastrophic condition. Most studies of APS pathogenesis to date have focused on the prothrombotic role of aPL, while innate immune components such as monocyte, complement and neutrophil activation have been recently recognized as part of the thrombo-inflammatory cascade in APS...
April 17, 2024: Clinical Immunology: the Official Journal of the Clinical Immunology Society
https://read.qxmd.com/read/38640930/25-hydroxycholesterol-regulates-lysosome-amp-kinase-activation-and-metabolic-reprogramming-to-educate-immunosuppressive-macrophages
#29
JOURNAL ARTICLE
Jun Xiao, Shuang Wang, Longlong Chen, Xinyu Ding, Yuanhao Dang, Mingshun Han, Yuxiao Zheng, Huan Shen, Sifan Wu, Mingchang Wang, Dan Yang, Na Li, Chen Dong, Miao Hu, Chen Su, Weiyun Li, Lijian Hui, Youqiong Ye, Huiru Tang, Bin Wei, Hongyan Wang
Macrophages are critical to turn noninflamed "cold tumors" into inflamed "hot tumors". Emerging evidence indicates abnormal cholesterol metabolites in the tumor microenvironment (TME) with unclear function. Here, we uncovered the inducible expression of cholesterol-25-hydroxylase (Ch25h) by interleukin-4 (IL-4) and interleukin-13 (IL-13) via the transcription factor STAT6, causing 25-hydroxycholesterol (25HC) accumulation. scRNA-seq analysis confirmed that CH25Hhi subsets were enriched in immunosuppressive macrophage subsets and correlated to lower survival rates in pan-cancers...
April 12, 2024: Immunity
https://read.qxmd.com/read/38640835/il-1-receptor-1-signaling-shapes-the-development-of-viral-antigen-specific-cd4-t-cell-responses-following-covid-19-mrna-vaccination
#30
JOURNAL ARTICLE
Hong-Jai Park, Min Sun Shin, Junghee J Shin, Hyoungsu Kim, Byunghyun Kang, Jennefer Par-Young, Serhan Unlu, Yuliya Afinogenova, Jason Catanzaro, Juan Young, Minhyung Kim, Sang Jin Lee, Sangchoon Jeon, Sungyong You, Michael K Racke, Richard Bucala, Insoo Kang
BACKGROUND: The innate immune cytokine interleukin (IL)-1 can affect T cell immunity, a critical factor in host defense. In a previous study, we identified a subset of human CD4+ T cells which express IL-1 receptor 1 (IL-1R1). However, the expression of such receptor by viral antigen-specific CD4+ T cells and its biological implication remain largely unexplored. This led us to investigate the implication of IL-1R1 in the development of viral antigen-specific CD4+ T cell responses in humans, including healthy individuals and patients with primary antibody deficiency (PAD), and animals...
April 18, 2024: EBioMedicine
https://read.qxmd.com/read/38640748/a-phase-i-study-to-evaluate-the-safety-pharmacokinetics-and-pharmacodynamics-of-pf-06939999-prmt5-inhibitor-in-patients-with-selected-advanced-or-metastatic-tumors-with-high-incidence-of-splicing-factor-gene-mutations
#31
JOURNAL ARTICLE
J Rodon, E Rodriguez, M L Maitland, F Y-C Tsai, M A Socinski, J D Berlin, J S Thomas, T Al Baghdadi, I-M Wang, C Guo, M Golmakani, L N Clark, M Gazdoiu, M Li, A W Tolcher
BACKGROUND: Protein arginine methyltransferase 5 (PRMT5) methylates multiple substrates dysregulated in cancer, including spliceosome machinery components. PF-06939999 is a selective small-molecule PRMT5 inhibitor. PATIENTS AND METHODS: This phase I dose-escalation and -expansion trial (NCT03854227) enrolled patients with selected solid tumors. PF-06939999 was administered orally once or twice a day (q.d./b.i.d.) in 28-day cycles. The objectives were to evaluate PF-06939999 safety and tolerability to identify maximum tolerated dose (MTD) and recommended part 2 dose (RP2D), and assess pharmacokinetics (PK), pharmacodynamics [changes in plasma symmetric dimethylarginine (SDMA) levels], and antitumor activities...
April 18, 2024: ESMO Open
https://read.qxmd.com/read/38640253/tim-3-cd8-t-cells-with-a-terminally-exhausted-phenotype-retain-functional-capacity-in-hematological-malignancies
#32
JOURNAL ARTICLE
Simone A Minnie, Olivia G Waltner, Ping Zhang, Shuichiro Takahashi, Nicole S Nemychenkov, Kathleen S Ensbey, Christine R Schmidt, Samuel R W Legg, Melissa Comstock, Julie R Boiko, Ethan Nelson, Shruti S Bhise, Alec B Wilkens, Motoko Koyama, Madhav V Dhodapkar, Marta Chesi, Stanley R Riddell, Damian J Green, Andrew Spencer, Scott N Furlan, Geoffrey R Hill
Chronic antigen stimulation is thought to generate dysfunctional CD8 T cells. Here, we identify a CD8 T cell subset in the bone marrow tumor microenvironment that, despite an apparent terminally exhausted phenotype (TPHEX ), expressed granzymes, perforin, and IFN-γ. Concurrent gene expression and DNA accessibility revealed that genes encoding these functional proteins correlated with BATF expression and motif accessibility. IFN-γ+ TPHEX effectively killed myeloma with comparable efficacy to transitory effectors, and disease progression correlated with numerical deficits in IFN-γ+ TPHEX ...
April 19, 2024: Science Immunology
https://read.qxmd.com/read/38640116/tumor-microenvironment-restricts-il-10-induced-multipotent-progenitors-to-myeloid-lymphatic-phenotype
#33
JOURNAL ARTICLE
Lisa Volk-Draper, Shaswati Athaiya, Maria Espinosa Gonzalez, Nihit Bhattarai, Andrew Wilber, Sophia Ran
Lymphangiogenesis is induced by local pro-lymphatic growth factors and bone marrow (BM)-derived myeloid-lymphatic endothelial cell progenitors (M-LECP). We previously showed that M-LECP play a significant role in lymphangiogenesis and lymph node metastasis in clinical breast cancer (BC) and experimental BC models. We also showed that differentiation of mouse and human M-LECP can be induced through sequential activation of colony stimulating factor-1 (CSF-1) and Toll-like receptor-4 (TLR4) pathways. This treatment activates the autocrine interleukin-10 (IL-10) pathway that, in turn, induces myeloid immunosuppressive M2 phenotype along with lymphatic-specific proteins...
2024: PloS One
https://read.qxmd.com/read/38639586/sialyl-lewis-x-defines-an-activated-and-functional-regulatory-t-cell-subpopulation-in-mice
#34
JOURNAL ARTICLE
Kanae Ohishi, Asaki Ishikura, Shogo Nishida, Hirohito Abo, Hiroko Nakatsukasa, Hiroto Kawashima
Attempts have been made to elucidate the functional markers of regulatory T cells (Tregs), CD4+Foxp3+ T cells with an immunosuppressive function. Sialyl Lewis X (sLex), a tetrasaccharide Ag, is involved in leukocyte trafficking as selectin ligands and is a marker of highly differentiated Tregs in humans. However, the importance of sLex in murine Tregs remains unknown. In this study, we report that sLex defines the activated and functional subset of murine Tregs. The contact hypersensitivity model showed that murine Tregs strongly express sLex upon activation, accompanied by functional Treg marker elevation, such as Foxp3, CD25, CD103, CD39, and granzyme B...
April 19, 2024: Journal of Immunology
https://read.qxmd.com/read/38638445/phenotypic-immune-characterization-of-gastric-and-esophageal-adenocarcinomas-reveals-profound-immune-suppression-in-esophageal-tumor-locations
#35
JOURNAL ARTICLE
Tessa S Groen-van Schooten, Micaela Harrasser, Jens Seidel, Emma N Bos, Tania Fleitas, Monique van Mourik, Roos E Pouw, Ruben S A Goedegebuure, Benthe H Doeve, Jasper Sanders, Joris Bos, Mark I van Berge Henegouwen, Victor L J L Thijssen, Nicole C T van Grieken, Hanneke W M van Laarhoven, Tanja D de Gruijl, Sarah Derks
BACKGROUND: Tumors in the distal esophagus (EAC), gastro-esophageal junction including cardia (GEJAC), and stomach (GAC) develop in close proximity and show strong similarities on a molecular and cellular level. However, recent clinical data showed that the effectiveness of chemo-immunotherapy is limited to a subset of GEAC patients and that EACs and GEJACs generally benefit less from checkpoint inhibition compared to GACs. As the composition of the tumor immune microenvironment drives response to (immuno)therapy we here performed a detailed immune analysis of a large series of GEACs to facilitate the development of a more individualized immunomodulatory strategy...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38638438/enrichment-of-type-1-innate-lymphoid-cells-in-the-course-of-human-atherosclerotic-plaque-development-suggests-contribution-to-atherogenesis
#36
JOURNAL ARTICLE
Kartika R Pertiwi, Marcel B M Teunissen, Gabrielle Krebbers, Martine C M Willems, Laurens Huisman, Cindy Poelen, Allard C van der Wal, Onno J de Boer
INTRODUCTION: Innate lymphoid cells (ILCs) have been implicated in multiple pathologic conditions, including atherogenesis, as documented in experimental mice studies, however, their role in atherosclerosis in humans remains unexplored. METHODS: Here, we identify ILCs and their dynamics in early, advanced, and complicated human carotid- and aortic atherosclerotic plaques, using a multiplex immunohistochemical quadruple-staining technique with prototypic transcription factors T-bet, GATA3, or RORgt for identification of the ILC1, ILC2 and ILC3 subsets, respectively, in combination with lineage markers CD3, CD20/ CD79a and CD56 to exclude other lymphoid cell types...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38637929/recognizing-complexity-of-cd8-t-cells-in-transplantation
#37
JOURNAL ARTICLE
Michael Nicosia, Anna Valujskikh
The major role of CD8+ T cells in clinical and experimental transplantation is well documented and acknowledged. Nevertheless, the precise impact of CD8+ T cells on graft tissue injury is not completely understood, thus impeding the development of specific treatment strategies. The goal of this overview is to consider the biology and functions of CD8+ T cells in the context of experimental and clinical allotransplantation, with special emphasis on how this cell subset is affected by currently available and emerging therapies...
April 19, 2024: Transplantation
https://read.qxmd.com/read/38637492/an-esophagus-cell-atlas-reveals-dynamic-rewiring-during-active-eosinophilic-esophagitis-and-remission
#38
JOURNAL ARTICLE
Jiarui Ding, John J Garber, Amiko Uchida, Ariel Lefkovith, Grace T Carter, Praveen Vimalathas, Lauren Canha, Michael Dougan, Kyle Staller, Joseph Yarze, Toni M Delorey, Orit Rozenblatt-Rosen, Orr Ashenberg, Daniel B Graham, Jacques Deguine, Aviv Regev, Ramnik J Xavier
Coordinated cell interactions within the esophagus maintain homeostasis, and disruption can lead to eosinophilic esophagitis (EoE), a chronic inflammatory disease with poorly understood pathogenesis. We profile 421,312 individual cells from the esophageal mucosa of 7 healthy and 15 EoE participants, revealing 60 cell subsets and functional alterations in cell states, compositions, and interactions that highlight previously unclear features of EoE. Active disease displays enrichment of ALOX15+ macrophages, PRDM16+ dendritic cells expressing the EoE risk gene ATP10A, and cycling mast cells, with concomitant reduction of TH 17 cells...
April 18, 2024: Nature Communications
https://read.qxmd.com/read/38637320/one-component-cationic-lipids-for-systemic-mrna-delivery-to-splenic-t-cells
#39
JOURNAL ARTICLE
Xinyue Zhang, Kexin Su, Shiqi Wu, Lixin Lin, Shun He, Xinxin Yan, Lu Shi, Shuai Liu
Unlocking the full potential of mRNA immunotherapy necessitates targeted delivery to specific cell subsets in the spleen. Four-component lipid nanoparticles (LNPs) utilized in numerous clinical trials are primarily limited in hepatocyte and muscular targeting, highlighting the imperative demand for targeted and simplified non-liver mRNA delivery systems. Herein, we report the rational design of one-component ionizable cationic lipids to selectively deliver mRNA to the spleen and T cells with high efficacy. Unlike the tertiary amine-based ionizable lipids involved in LNPs, the proposed cationic lipids rich in secondary amines can efficiently deliver mRNA both in vitro and in vivo as the standalone carriers...
April 18, 2024: Angewandte Chemie
https://read.qxmd.com/read/38637134/potential-and-pitfalls-of-repurposing-the-car-t-cell-regimen-for-the-treatment-of-autoimmune-disease
#40
JOURNAL ARTICLE
Andrea R Daamen, Peter E Lipsky
Chimeric antigen receptors (CARs) are synthetic proteins designed to direct an immune response toward a specific target and have been used in immunotherapeutic applications through the adoptive transfer of T cells genetically engineered to express CARs. This technology received early attention in oncology with particular success in treatment of B cell malignancies leading to the launch of numerous successful clinical trials and the US Food and Drug Administration approval of several CAR-T-based therapies. Many CAR-T constructs have been employed, but have always been administered following a lymphodepletion regimen...
April 18, 2024: Annals of the Rheumatic Diseases
keyword
keyword
15718
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.